Sort
25,944 grants matching “neurodegeneration”
ATM and DNA Damage in the Nervous System
$382,813Peter J McKinnon · St. Jude Children'S Research Hospital · R01 · FY2015 · NS
Role of C9orf72 in Neurodegeneration
$382,813Robert Harris Baloh · Cedars-Sinai Medical Center · R01 · FY2017 · NS
Long-term effects of botulinum neurotoxins on neuronal viability
$382,812Min Dong · Brigham And Women'S Hospital · R01 · FY2015 · NS
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$382,766Craig C Weinkauf · University Of Arizona · R01 · FY2023 · AG
Effects of the Sleep/Wake Cycle on A-Beta, Tau and Spreading
$382,665David M Holtzman · Washington University · P01 · FY2020 · NS
Role of Parkin in Familial and Idiopathic Parkinson's Disease
$382,659Matthew J Lavoie · Brigham And Women'S Hospital · R01 · FY2012 · NS
Molecular Basis of Syndromic Retinitis Pigmentosa
$382,632Oregon Health And Science University · R01 · FY2004 · EY
Polyglutamine conformation and neurodegeneration
$382,613J. David Gladstone Institutes · R01 · FY2004 · NS
Polyglutamine conformation and neurodegeneration
$382,613J. David Gladstone Institutes · R01 · FY2003 · NS
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$382,586John A. Hanover · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$382,586John A. Hanover · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Altered Hippocampal Neurogenesis and Cognition via Maneb-mediated Changes in the Thiol Redox Proteome.
$382,573James R Roede · University Of Colorado Denver · R01 · FY2020 · ES
Neuropathology in tauopathies stem from depolarization-induced alterations in the planar distribution of phosphoinositides
$382,528Kartik Venkatachalam · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AG
CNTF and retinal degeneration: the role of Muller cells
$382,500Rong Wen · University Of Miami School Of Medicine · R01 · FY2009 · EY
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$382,500Elizabeth Head · University Of California-Irvine · R01 · FY2021 · AG
AD supplement to In vivo patterns of receptor activation by odorants
$382,500Timothy S McClintock · University Of Kentucky · R01 · FY2019 · DC
The Kansas Institute for Precision Medicine
$382,500Andrew K Godwin · University Of Kansas Medical Center · P20 · FY2020 · GM
Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases
$382,500Komaraiah Palle · Texas Tech University Health Scis Center · R01 · FY2022 · CA
Treatment of Lafora disease with an antibody-enzyme fusion
$382,500Matthew S. Gentry · University Of Kentucky · R61 · FY2020 · NS
Dynamic and Static Autoregulation Impairment in the Optic Nerve Head of Glaucoma
$382,500Lin Wang · Legacy Emanuel Hospital And Health Center · R01 · FY2010 · EY
Progranulin, TAR DNA binding protein-43 and Cell Death
$382,500Leonard Petrucelli · Mayo Clinic Jacksonville · R56 · FY2009 · AG
Characterization of the Sch9 Longevity Pathway in Yeast
$382,500Robert C Dickson · University Of Kentucky · R56 · FY2017 · AG
Limbic System Function in Carriers of the Fragile X Premutation
$382,500David R Hessl · University Of California At Davis · R01 · FY2011 · MH
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential
$382,500Matthew S. Gentry · University Of Kentucky · R35 · FY2021 · NS
CNTF and retinal degeneration: the role of Muller cells
$382,500Rong Wen · University Of Miami School Of Medicine · R01 · FY2008 · EY